India's Sun Pharma acquires U.S.-based Pharmalucence
MUMBAI, July 16
MUMBAI, July 16 (Reuters) - Sun Pharmaceutical Industries Ltd, India's third-largest generic drugmaker by sales, said on Wednesday it had acquired U.S.-based Pharmalucence Inc, which has sterile injectable capacity and research capabilities.
Financial details of the deal were not disclosed. (Reporting by Sumeet Chatterjee; Editing by Prateek Chatterjee)